Sophie Mukadam's most recent trade in Benitec Biopharma Inc was a trade of 500,000 Options (right to buy) done . Disclosure was reported to the exchange on Nov. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Benitec Biopharma Inc | Sophie Mukadam | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 500,000 | 500,000 | - | - | Options (right to buy) |